In your fight with Cancer, we are with you. We understand the complexity and side effects of Cancer treatment and therefore, bring the technology to help you get the most effective treatment.
In fact, Cancer is the second leading cause of deaths worldwide and accounts for a share of 13 percent in total global deaths (or 8.7 million deaths).
Cancer diagnosis brings a shock not only because of high treatment cost, but also because of the poor chances of survival and mental pressure.
Cancer can be cured when treated at an early stage with the right therapy, but the genetic mutation and drug resistance make it challenging, and hence, chances of recurrence arise.
If the treatment is done but because of mutation cancer reoccurs then it is treated with another therapy and so on. This guess and hit based treatment costs much more. The time spent on treatment, cost of treatment and progress of cancer stage make it complex and fatal. One more challenge in cancer treatment is different drug efficacy in different person because of individual immunity and drug resistance.
But now with advanced 3D cell culture analyses, Clyz Labs can find the most accurate therapy for individual patient measuring the individual immunity and drug resistance.
CanCertain is a 3D-based cell culture analysis. 3D-based analysis mimics the natural human environment in a laboratory so as to provide the most efficacious personalized treatment plan.
Taking the CLYZ CanCertain test is easy and fast. Fresh Blood Samples from solid or fluid tumours will be obtained from the biopsy or surgery of the patient. Those samples will be sent to the CLYZ Labs to conduct the CanCertain Test with a variety of chemotherapy / immunotherapy drugs along with the blood test. The test results for the same will be available in 8 to 10 days.
In this analysis, our scientists find the most accurate treatment therapy for the individual patients so cancer can be cured in the shortest possible time, avoiding the side effects of unnecessary drugs.
In CanCertain test sensitivity is found by determining the level of effectiveness of certain chemo-agents against cancer cells of the individual patient. In the opposite way, the results of the Chemosenstivity test also determines the drug resistance which means offering information about which cancer cells of the patient continue living and growing despite receiving the drug.
With the results of this test, the patients do not need to go through a “guess and check” treatment with the drugs and they can protect their immune system from the beginning of the treatment.
WHO WILL BE ABLE
TO TAKE THE TEST:
Our current clinical trials have been on Lung Cancer but the CanCertain Test is suitable for any patient diagnosed with Cancer, at any stage of the disease. Those who take the test before starting the first treatment will benefit most.
BENEFITS OF THE
Recommended treatment on the basis of the CanCertain Test will improve the quality of life of patient by providing the most accurate treatment, saving time and money, by not spending on guess-based treatment and therefore, avoiding side effects of unnecessary drugs.